The African turquoise killifish, which lives only four to six months, has been transformed into a platform for genetic research with the help of CRISPR/Cas9 genome editing.
The partners are the Wellcome Trust Sanger Institute, The Innovative Genomics Initiative, Thermo Fisher Scientific, and the Broad and Whitehead Institutes.
Novartis looks toward employing the CRISPR genome-editing tool to develop new therapeutics and as a research tool.
The arrangement covers Cellectis' TALEN technology and Two Blades' TAL effector code technology.
Technology Review examines who owns the CRISPR/Cas9 gene editing approach.
The licenses provide non-exclusive access to the IP for research applications.
NEW YORK (GenomeWeb) – Researchers from New York University Langone School of Medicine have developed a synthetic biology method to linearize circular DNA molecules in vivo.
NEW YORK (GenomeWeb) – Clontech Laboratories today announced a non-exclusive licensing deal with the Broad Institute for its CRISPR-Cas9 technology.
NEW YORK (GenomeWeb) – Horizon Discovery Group today announced the acquisition of Sage Labs, a provider of research models and transgenic support services, for up to $48 million.
NEW YORK (GenomeWeb) – Kultevat today said it has exclusively licensed technology to control plant gene expression from the Donald Danforth Plant Science Center.
As the Canadian election season heats up, neither major party has really paid much attention to science, according to Nature News.
BBC News says the uncertainty over Brexit is affecting science funding in the UK.
A new app purports to tell users "how gay" they are by looking at their DNA, but experts tell Futurism that the app is bunk.
In Nature this week: human and great ape cerebral organoids reveal aspects of brain development unique to humans, and more.